SEC Form 4 · accession 0001127602-15-012316
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric K Rowinsky
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 23, 2015 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | M | 11,667 | $59.82 | A | 22,977 | D | |
| Common Stock | Mar 20, 2015 | S | 11,667 | $475.00 | D | 11,310 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $59.82 | Mar 20, 2015 | M | 11,667 | D | — | Mar 22, 2020 | Common Stock | 11,667 | 0 | D |
Explanation of responses
- F1Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010.